Open AccessA Hybrid Soluble gp130/Spike-Nanobody Fusion Protein Simultaneously Blocks Interleukin-6 trans -Signaling and Cellular Infection with SARS-CoV-2
Author(s) -
Julia Ettich,
Julia Werner,
Hendrik T. Weitz,
Eva Mueller,
Roland Schwarzer,
Philipp A. Lang,
Jürgen Scheller,
Jens M. Moll
Publication year - 2021
Publication title -
journal of virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.617
H-Index - 292
eISSN - 1070-6321
pISSN - 0022-538X
DOI - 10.1128/jvi.01622-21
Subject(s) - glycoprotein 130 , biology , cytokine , antibody , signal transduction , coronavirus , fusion protein , immunology , virology , monoclonal antibody , receptor , interleukin 6 , microbiology and biotechnology , medicine , disease , covid-19 , recombinant dna , biochemistry , infectious disease (medical specialty) , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom